Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayal Aaron Aizer, M.D.

Co-Author

This page shows the publications co-authored by Ayal Aizer and Raymond Huang.
Connection Strength

0.908
  1. Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis. Korean J Radiol. 2021 04; 22(4):584-595.
    View in: PubMed
    Score: 0.235
  2. Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis. Eur Radiol. 2021 Jun; 31(6):4114-4129.
    View in: PubMed
    Score: 0.235
  3. A low percentage of metastases in deep brain and temporal lobe structures. Neuro Oncol. 2019 05 06; 21(5):640-647.
    View in: PubMed
    Score: 0.211
  4. Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis. AJR Am J Roentgenol. 2021 Sep 09; 1-10.
    View in: PubMed
    Score: 0.062
  5. Identification and Characterization of Leptomeningeal Metastases Using SPINE, A Web-Based Collaborative Platform. J Neuroimaging. 2021 03; 31(2):324-333.
    View in: PubMed
    Score: 0.059
  6. Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer. Radiology. 2020 11; 297(2):419-427.
    View in: PubMed
    Score: 0.058
  7. Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS One. 2017; 12(11):e0187908.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.